Applied Clinical Intelligence will begin doing business as ACI Clinical, effective Jan. 1, to better reflect the organization's services related to Endpoint Adjudication Committees (EAC) and Data Monitoring Committees (DMC) in clinical research. With the adoption of its new name, logo and corporate offices, ACI Clinical also has launched a redesigned web site.
The company has supported more than 20 regulatory approved products and numerous publications. ACI has managed 100+ EACs and has introduced a unique risk-based model for DMCs to be more effective and cost-efficient for sponsors.
"This rebranding reflects the evolution of the organization over the past 12 years into a provider of independent committee management solutions," said Jonathan Seltzer, president and CEO of ACI Clinical. "Study endpoints often are the most important aspect of the data, and they require special expertise. Our team openly and honestly advises clients on the best route to success—whether it be an independent committee, no committee at all or a risk-based approach to save unnecessary costs."
In addition to full-service independent committee solutions, for which ACI Clinical maintains a global network of pre-vetted clinical and statistical experts, the company also continues to provide data services and advisory services.